idarubicin has been researched along with Carcinoma, Anaplastic in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hofman, J; Malcekova, B; Novotna, E; Skarka, A; Wsol, V | 1 |
| Kimura, F; Miyazaki, M; Ohtsuka, M; Seki, N; Shimizu, H; Sugimoto, T; Washiro, M; Yoshidome, H | 1 |
| Alken, P; Köhrmann, KU; Kreukler, C; Siegsmund, MJ; Stendler, A | 1 |
| Bruzzone, M; Chiara, S; Conte, PF; Falcone, A; Graziani, G; Rosso, R | 1 |
| Casper, ES; Currie, VE; Hakes, TB; Kaufman, RJ; Raymond, V | 1 |
5 other study(ies) available for idarubicin and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Anthracycline resistance mediated by reductive metabolism in cancer cells: the role of aldo-keto reductase 1C3.
Topics: 3-Hydroxysteroid Dehydrogenases; Aldo-Keto Reductase Family 1 Member C3; Anthracyclines; Antibiotics, Antineoplastic; Biotransformation; Carcinoma; Cell Line, Tumor; Cell Survival; Daunorubicin; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Induction; Enzyme Inhibitors; Flavanones; Humans; Hydroxyprostaglandin Dehydrogenases; Idarubicin; Kinetics; Neoplasm Proteins; Oxidation-Reduction; Recombinant Proteins | 2014 |
Upregulation of topoisomerase IIalpha expression in advanced gallbladder carcinoma: a potential chemotherapeutic target.
Topics: Aged; Antigens, Neoplasm; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Blotting, Western; Carcinoma; Cell Proliferation; Deoxycytidine; DNA Topoisomerases, Type II; DNA-Binding Proteins; Doxorubicin; Etoposide; Female; Gallbladder Neoplasms; Gemcitabine; Gene Expression; Gene Expression Profiling; Humans; Idarubicin; Immunohistochemistry; Male; Oligonucleotide Array Sequence Analysis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Up-Regulation | 2008 |
Enhanced in vitro cytotoxicity of idarubicin compared to epirubicin and doxorubicin in rat prostate carcinoma cells.
Topics: Animals; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma; Cell Division; Doxorubicin; Drug Resistance, Multiple; Epirubicin; Humans; Idarubicin; KB Cells; Lethal Dose 50; Male; Prostatic Neoplasms; Rats; Tumor Cells, Cultured | 1997 |
4-Demethoxydaunorubicin (IMI-30) in refractory epithelial ovarian cancer: a pilot study.
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma; Daunorubicin; Drug Resistance; Female; Humans; Idarubicin; Middle Aged; Ovarian Neoplasms | 1987 |
Phase II evaluation of orally administered idarubicin in patients with advanced breast cancer.
Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Carcinoma; Daunorubicin; Drug Evaluation; Female; Humans; Idarubicin; Middle Aged | 1987 |